Search results
After losing 5.2% in the past year, Xenon Pharmaceuticals Inc. (NASDAQ:XENE) institutional owners...
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights Significantly high institutional ownership implies Xenon Pharmaceuticals' stock price...
Is Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Trading At A 39% Discount?
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Xenon Pharmaceuticals fair value estimate...
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Analysts Just Trimmed Their Revenue Forecasts By 10%
Simply Wall St. via Yahoo Finance· 2 years agoMarket forces rained on the parade of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) shareholders today,...
What Does The Future Hold For Xenon Pharmaceuticals Inc. (NASDAQ:XENE)? These Analysts Have Been...
Simply Wall St. via Yahoo Finance· 2 years agoOne thing we could say about the analysts on Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - they aren't...
Xenon Pharmaceuticals Stock Scores Rising Relative Strength Upgrade
Investor's Business Daily· 1 year agoXenon Pharmaceuticals stock had its Relative Strength (RS) Rating upgraded from 89 to 92 Tuesday. Is...
What Makes Xenon Pharmaceuticals (XENE) a New Buy Stock
Zacks via Yahoo Finance· 3 weeks agoXenon Pharmaceuticals (XENE) might move higher on growing optimism about its earnings prospects,...
Insider Sell: EVP, Strategy & Innovation Sherrington Robin Sells 7,137 Shares of Xenon ...
GuruFocus.com via Yahoo Finance· 3 months agoXenon Pharmaceuticals Inc (NASDAQ:XENE), a clinical-stage biopharmaceutical company, focuses on...
Xenon Pharmaceuticals (XENE) Expected to Beat Earnings Estimates: Should You Buy?
Zacks via Yahoo Finance· 1 year agoXenon Pharmaceuticals (XENE) possesses the right combination of the two key ingredients for a likely...
Xenon Pharmaceuticals (XENE) Reports Q2 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 10 months agoXenon Pharmaceuticals (XENE) delivered earnings and revenue surprises of -4.35% and 100%,...
Wall Street Analysts Believe Xenon Pharmaceuticals (XENE) Could Rally 36.75%: Here's is How to Trade
Zacks via Yahoo Finance· 9 months agoThe average of price targets set by Wall Street analysts indicates a potential upside of 36.8% in...